⌘K

Home/Filings/4/0001225208-24-003207

4//SEC Filing

Fonseca Lidia 4

Accession 0001225208-24-003207

CIK 0000078003other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 5:00 PM ET

Size

7.6 KB

Accession

0001225208-24-003207

Insider Transaction Report

Form 4

Period: 2024-02-27

Executive Vice President

Transactions

Award
Stock Appreciation Rights
2024-02-27+60,124→ 60,124 total
Exercise: $26.89From: 2031-02-27Exp: 2031-02-27→ Common Stock (60,124 underlying)
Award
Stock Appreciation Rights
2024-02-27+68,045→ 68,045 total
Exercise: $26.89From: 2029-02-27Exp: 2029-02-27→ Common Stock (68,045 underlying)

Footnotes (2)

[F1]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
[F2]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

4
doc4.xmlPrimary

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1

filerCIK 0001454944

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 5:00 PM ET
Size: 7.6 KB

View on SEC.gov